Erythropoietin Biosimilar Market Overview The Erythropoietin Biosimilar Market represents a rapidly growing segment within the biopharmaceutical industry, focusing on biosimilar alternatives to recombinant erythropoietin. These biosimilars are used to treat anemia associated with chronic kidney disease (CKD), cancer chemotherapy, HIV-related anemia, and other conditions. With the...